Clinical Trial Update: Trikafta Exercise Study in Cystic Fibrosis

View source ↗

Summary

A clinical trial evaluating the effects of Trikafta in individuals with cystic fibrosis focusing on exercise is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: University of British Columbia | Conditions: Cystic Fibrosis, Lung Diseases | Status: RECRUITING